Skip to main content
Top
Published in: Diagnostic Pathology 1/2016

Open Access 01-12-2016 | Research

Quality of sweat test (ST) based on the proportion of sweat sodium (Na) and sweat chloride (Cl) as diagnostic parameter of cystic fibrosis: are we on the right way?

Authors: Alethéa Guimarães Faria, Fernando Augusto Lima Marson, Carla Cristina de Souza Gomez, Maria Ângela Gonçalves de Oliveira Ribeiro, Lucas Brioschi Morais, Maria de Fátima Servidoni, Carmen Sílvia Bertuzzo, Eulália Sakano, Maura Goto, Ilma Aparecida Paschoal, Mônica Corso Pereira, Gabriel Hessel, Carlos Emílio Levy, Adyléia Aparecida Dalbo Contrera Toro, Andressa Oliveira Peixoto, Maria Cristina Ribeiro Simões, Elizete Aparecida Lomazi, Roberto José Negrão Nogueira, Antônio Fernando Ribeiro, José Dirceu Ribeiro

Published in: Diagnostic Pathology | Issue 1/2016

Login to get access

Abstract

Background

To assess the quality of sweat test (ST) based on the proportion of sweat sodium and sweat chloride as diagnostic parameter of cystic fibrosis (CF).

Methods

A retrospective study of 5,721 sweat samples and subsequent descriptive analysis were carried out. The test was considered “of good quality” (correct) when: (i) sweat chloride was lower than 60 mEq/L, and sweat sodium was higher than sweat chloride; (ii) sweat chloride was higher than 60 mEq/L, and sweat sodium was lower than sweat chloride.

Results

The study included 5,692/5,721 sweat samples of ST which had been requested due to clinical presentations compatible with CF and/or neonatal screenings with altered immunoreactive trypsinogen values. Considering the proportion of sweat sodium and sweat chloride as ST quality parameter, the test was performed correctly in 5,023/5,692 (88.2 %) sweat samples. The sweat chloride test results were grouped into four reference ranges for chloride (i) chloride < 30 mEq/L: 3,651/5,692 (64.1 %); (ii) chloride ≥ 30 mEq/L to < 40 mEq/L: 652/5,692 (11.5 %); (iii) ≥ 40 mEq/L to < 60 mEq/L: 673/5,692 (11.8 %); (iv) ≥ 60 mEq/L: 716/5,692 (12.6 %). In the comparative analysis, there was no association between ST quality and: (i) symptoms to indicate a ST [respiratory (p = 0.084), digestive (p = 0.753), nutritional (p = 0.824), and others (p = 0.136)], (ii) sweat weight (p = 0.416). However, there was a positive association with: (i) gender, (ii) results of ST (p < 0.001), (iii) chloride/sodium ratio (p < 0.001), (iv) subject’s age at the time of ST [grouped according to category (p < 0.001) and numerical order (p < 0.001)]. For the subset of 169 patients with CF and two CFTR mutations Class I, II and/or III, in comparative analysis, there was a positive association with: (i) sweat chloride/sodium ratio (p < 0.001), (ii) sweat chloride values (p = 0.047), (iii) subject’s age at the time of the ST grouped by numerical order (p = 0.001).

Conclusions

Considering that the quality of ST can be assessed by levels of sweat sodium and sweat chloride, an increasing number of low-quality tests could be observed in our sweat samples. The quality of the test was associated with important factors, such as gender, CF diagnosis, and subjects’ age.
Literature
1.
go back to reference Collie JT, Massie RJ, Jones OH, LeGrys VA, Greaves RF. Sixty five years since the New York heat Wave: Advances in sweat testing for Cystic Fibrosis. Pediatr Pulmonol. 2014;49:106–17.CrossRefPubMed Collie JT, Massie RJ, Jones OH, LeGrys VA, Greaves RF. Sixty five years since the New York heat Wave: Advances in sweat testing for Cystic Fibrosis. Pediatr Pulmonol. 2014;49:106–17.CrossRefPubMed
2.
go back to reference Traeger N, Shi Q, Dozor AJ. Relationship between sweat chloride, sodium, and age in clinically obtained samples. J of Cyst Fibros. 2014;13:10–4.CrossRef Traeger N, Shi Q, Dozor AJ. Relationship between sweat chloride, sodium, and age in clinically obtained samples. J of Cyst Fibros. 2014;13:10–4.CrossRef
4.
go back to reference McKone F, Velentgas P, Swenson A, Goss C. Association of sweat chloride concentration at time of diagnosis and CFTR genotype with mortality and cystic fibrosis phenotype. J of Cyst Fibros. 2015;14:580–6.CrossRef McKone F, Velentgas P, Swenson A, Goss C. Association of sweat chloride concentration at time of diagnosis and CFTR genotype with mortality and cystic fibrosis phenotype. J of Cyst Fibros. 2015;14:580–6.CrossRef
5.
go back to reference Levy H, Farrell P. New challenges in the diagnosis and management of cystic fibrosis. J of Pediatrics. 2015;166:1337–40.CrossRef Levy H, Farrell P. New challenges in the diagnosis and management of cystic fibrosis. J of Pediatrics. 2015;166:1337–40.CrossRef
6.
go back to reference Ng RT, Marson FA, Ribeiro JD, Ribeiro AF, Bertuzzo CS, Ribeiro MA, Severino SD, Sakano E. Nasal potential difference in cystic fibrosis considering severe CFTR mutations. Dis Markers. 2015;2015:306825.CrossRefPubMedPubMedCentral Ng RT, Marson FA, Ribeiro JD, Ribeiro AF, Bertuzzo CS, Ribeiro MA, Severino SD, Sakano E. Nasal potential difference in cystic fibrosis considering severe CFTR mutations. Dis Markers. 2015;2015:306825.CrossRefPubMedPubMedCentral
7.
go back to reference Gonska T, Ip W, Turner D, Han W, Rose J, Durie P, Quinton P. Sweat gland bioeletrics differ in cystic fibrosis: a new concept for potential diagnosis and assessment of CFTR function in cystic fibrosis. Thorax. 2009;64:932–8.CrossRefPubMed Gonska T, Ip W, Turner D, Han W, Rose J, Durie P, Quinton P. Sweat gland bioeletrics differ in cystic fibrosis: a new concept for potential diagnosis and assessment of CFTR function in cystic fibrosis. Thorax. 2009;64:932–8.CrossRefPubMed
8.
9.
go back to reference Quinton P, Molyneux L, Ip W, Dupuis A, Avolio J, Tullis E, et al. Beta adrenergic sweat secretion as a diagnostic test for cystic Fibrosis. Am J Respir Crit Care Med. 2012;186(8):732–9.CrossRefPubMed Quinton P, Molyneux L, Ip W, Dupuis A, Avolio J, Tullis E, et al. Beta adrenergic sweat secretion as a diagnostic test for cystic Fibrosis. Am J Respir Crit Care Med. 2012;186(8):732–9.CrossRefPubMed
10.
go back to reference Quinton P. Cystic Fibrosis: lessons from the sweat gland. Phisiology. 2007;22:212–55. Quinton P. Cystic Fibrosis: lessons from the sweat gland. Phisiology. 2007;22:212–55.
11.
go back to reference Mishra A, Greaves R, Massie J. The limitation of sweat electrolyte reference intervals for the diagnosis of cystic fibrosis: a systemic review. Clin Biochem Rev. 2007;28:60–6.PubMedCentral Mishra A, Greaves R, Massie J. The limitation of sweat electrolyte reference intervals for the diagnosis of cystic fibrosis: a systemic review. Clin Biochem Rev. 2007;28:60–6.PubMedCentral
12.
go back to reference Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J of Pediatr. 2008;153(2):S4–S14.CrossRef Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J of Pediatr. 2008;153(2):S4–S14.CrossRef
13.
go back to reference Mirsha A, Greaves R, Smith K, Carlin J, Wootton A, Stirling R, et al. Diagnosis of Cystic Fibrosis by Sweat Testing: Age-Specific Reference Intervals. J of Pediatr. 2008;153:758–63.CrossRef Mirsha A, Greaves R, Smith K, Carlin J, Wootton A, Stirling R, et al. Diagnosis of Cystic Fibrosis by Sweat Testing: Age-Specific Reference Intervals. J of Pediatr. 2008;153:758–63.CrossRef
14.
go back to reference Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics. 1959;23(5):545–9.PubMed Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics. 1959;23(5):545–9.PubMed
15.
go back to reference SPSS. 21.0 for windows (computer program): Statistical Package for Social Science (SPSS). Release version 21.0. Chicago: SPSS. Incorporation; 2012. SPSS. 21.0 for windows (computer program): Statistical Package for Social Science (SPSS). Release version 21.0. Chicago: SPSS. Incorporation; 2012.
16.
go back to reference Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175–91.CrossRefPubMed Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175–91.CrossRefPubMed
17.
go back to reference Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behav Res Methods. 2009;41:1149–60.CrossRefPubMed Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behav Res Methods. 2009;41:1149–60.CrossRefPubMed
18.
go back to reference Beauchamp M, Lands LC. Sweat testing: a review of current technical requirements. Pediatr Pulmonol. 2005;39:507–11.CrossRefPubMed Beauchamp M, Lands LC. Sweat testing: a review of current technical requirements. Pediatr Pulmonol. 2005;39:507–11.CrossRefPubMed
19.
go back to reference Christiansen A, Nybo M. Lack of harmonization in sweat testing for cystic fibrosis-a national survey. Scandinavian J of Clin Investigation. 2014;74:708–12.CrossRef Christiansen A, Nybo M. Lack of harmonization in sweat testing for cystic fibrosis-a national survey. Scandinavian J of Clin Investigation. 2014;74:708–12.CrossRef
20.
go back to reference O’ Sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009;54:595–605. O’ Sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009;54:595–605.
21.
go back to reference Groves T, Robinson P, Wiley V, Fitzgerald D. Long term outcomes of children with intermediate sweat chloride values in infancy. J of Pediatr. 2015;166(6):1469–74.CrossRef Groves T, Robinson P, Wiley V, Fitzgerald D. Long term outcomes of children with intermediate sweat chloride values in infancy. J of Pediatr. 2015;166(6):1469–74.CrossRef
22.
go back to reference Ren M, Desai H, Platt M, Dixon M. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome. Pediatr Pulmonol. 2011;46:1079–84.CrossRefPubMed Ren M, Desai H, Platt M, Dixon M. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome. Pediatr Pulmonol. 2011;46:1079–84.CrossRefPubMed
23.
go back to reference Eng W, LeGrys V, Schecheter M, Laughon M, Barker P. Sweat testing in pre term and full term infants less than 6 weeks of age. Pediatr Pulmonol. 2005;40:64–7.CrossRefPubMed Eng W, LeGrys V, Schecheter M, Laughon M, Barker P. Sweat testing in pre term and full term infants less than 6 weeks of age. Pediatr Pulmonol. 2005;40:64–7.CrossRefPubMed
24.
go back to reference Hall SK, Stableforth DE, Green A. Sweet sodium and chloride concentrations-essential criteria for the diagnosis of cystic fibrosis in adults. Ann Clin Biochem. 1990;27(4):576–8.CrossRef Hall SK, Stableforth DE, Green A. Sweet sodium and chloride concentrations-essential criteria for the diagnosis of cystic fibrosis in adults. Ann Clin Biochem. 1990;27(4):576–8.CrossRef
25.
go back to reference Mattar A, Gomes E, Adde F, Leone C, Rodrigues J. Comparison between classic Gibson and Cooke technique and sweat conductivity test in patients without cystic fibrosis. J Pediatr (Rio J). 2010;86:109–14. Mattar A, Gomes E, Adde F, Leone C, Rodrigues J. Comparison between classic Gibson and Cooke technique and sweat conductivity test in patients without cystic fibrosis. J Pediatr (Rio J). 2010;86:109–14.
26.
go back to reference Leig M. Diagnosis of CF despite normal or borderline sweat chloride. Paediatric Respir Rev. 2004;5:357–9.CrossRef Leig M. Diagnosis of CF despite normal or borderline sweat chloride. Paediatric Respir Rev. 2004;5:357–9.CrossRef
Metadata
Title
Quality of sweat test (ST) based on the proportion of sweat sodium (Na) and sweat chloride (Cl) as diagnostic parameter of cystic fibrosis: are we on the right way?
Authors
Alethéa Guimarães Faria
Fernando Augusto Lima Marson
Carla Cristina de Souza Gomez
Maria Ângela Gonçalves de Oliveira Ribeiro
Lucas Brioschi Morais
Maria de Fátima Servidoni
Carmen Sílvia Bertuzzo
Eulália Sakano
Maura Goto
Ilma Aparecida Paschoal
Mônica Corso Pereira
Gabriel Hessel
Carlos Emílio Levy
Adyléia Aparecida Dalbo Contrera Toro
Andressa Oliveira Peixoto
Maria Cristina Ribeiro Simões
Elizete Aparecida Lomazi
Roberto José Negrão Nogueira
Antônio Fernando Ribeiro
José Dirceu Ribeiro
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2016
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/s13000-016-0555-6

Other articles of this Issue 1/2016

Diagnostic Pathology 1/2016 Go to the issue